Wednesday, March 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home AI & Quantum Computing

AMD Secures Key Intel Executive Amid Market Volatility

Robert Sasse by Robert Sasse
November 10, 2025
in AI & Quantum Computing, Analysis, Semiconductors, Tech & Software
0
AMD Stock
0
SHARES
141
VIEWS
Share on FacebookShare on Twitter

Advanced Micro Devices (AMD) has made a significant strategic move in the intensifying artificial intelligence race by recruiting a top executive from rival Intel. This personnel shift comes as AMD’s stock experiences a pullback from record highs, despite the company posting exceptionally strong quarterly results that surpassed market expectations.

A Strategic Hire in the AI Battlefield

In a notable industry development, AMD has successfully hired Saurabh Kulkarni, who previously served as Intel’s Vice President responsible for product management of AI systems and GPUs within the data center division. His final day at Intel was Friday, November 7. This recruitment occurs at a pivotal moment for AMD as it accelerates its challenge to Nvidia’s dominance in the AI accelerator market while simultaneously applying competitive pressure across Intel’s business segments.

The acquisition represents a substantial knowledge transfer from a direct competitor, particularly valuable in the data center AI segment that industry observers consider crucial for the future trajectory of the semiconductor industry.

Strong Fundamentals Meet Market Jitters

The executive appointment news emerged during a turbulent trading period for AMD shares. Despite reporting record third-quarter performance with revenue reaching $9.25 billion (representing 36% year-over-year growth) and earnings per share of $1.20—both metrics exceeding analyst forecasts—the stock declined substantially. Shares dropped more than 7% during Thursday’s session alone, contributing to a weekly decline of approximately 9%.

Should investors sell immediately? Or is it worth buying AMD?

Key highlights from the Q3 earnings report:
* Record revenue of $9.25 billion (+36% YoY)
* Data center segment revenue: $4.3 billion (+22% YoY)
* Q4 guidance: approximately $9.6 billion (+25% YoY expected)
* Primary growth drivers: Instinct AI accelerators and EPYC processors

Market analysts attribute the share price decline to profit-taking following the stock’s substantial rally and ongoing concerns about valuation levels. Despite AMD’s impressive recent performance, even these outstanding quarterly results proved insufficient to fuel further momentum given the elevated expectations. While financial institutions including CICC, Rosenblatt, JPMorgan, and UBS reaffirmed their positive ratings, market participants remained cautious.

Upcoming Strategic Showcase

Investor attention now turns to November 11, when AMD hosts its Financial Analyst Day in New York. CEO Lisa Su and her executive team are scheduled to present the company’s long-term strategy, product roadmap, and financial planning. The presentation is expected to focus heavily on the future development of the Zen processor architecture, the roadmap for Instinct AI accelerators positioned as direct competitors to Nvidia’s dominant products, and detailed plans for scaling the AI business operations.

This event represents the next critical test for AMD’s leadership: demonstrating convincingly how the company justifies its aggressive valuation while continuing to expand market share in the data center segment. The newly acquired Intel executive may serve as a symbolic representation of AMD’s growing competitive strength in the battle for AI industry leadership.

Ad

AMD Stock: Buy or Sell?! New AMD Analysis from March 25 delivers the answer:

The latest AMD figures speak for themselves: Urgent action needed for AMD investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from March 25.

AMD: Buy or sell? Read more here...

Tags: AMD
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

Talphera Stock
Analysis

Talphera Shares Slide as Funding Concerns Overshadow Clinical Progress

March 25, 2026
Hain Celestial Stock
Analysis

Hain Celestial Sheds Snack Division in Strategic Overhaul

March 25, 2026
Technology Select Sector SPDR® Fund Stock
AI & Quantum Computing

Technology Sector Faces Mounting Headwinds as AI Hype Meets Macroeconomic Reality

March 25, 2026
Next Post
Bloom Energy Stock

Bloom Energy Shares Plunge Following Insider Stock Disposals

Bitcoin Stock

Bitcoin at a Critical Juncture: Veteran Exodus Meets Institutional Interest

DeFi Technologies Stock

DeFi Technologies' Trading Unit Scores Major Arbitrage Victory

Recommended

Alphabet Stock

Alphabet Shares Surge as Antitrust Victory Sparks Market Rally

7 months ago
Invesco DB US Dollar Index Bullish Fund Stock

Geopolitical Tensions Fuel Dollar Strength and Spotlight on Invesco’s Bullish ETF

2 weeks ago
BayWa Stock

BayWa Faces Multifaceted Crisis as Restructuring Plan Unravels

3 days ago
Merit Medical Stock

Merit Medical Shares Await Key Catalysts for Momentum Shift

6 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Lumen’s AI Infrastructure Push Gains Recognition Amid Strategic Overhaul

Microsoft’s AI Ambitions Strain Finances as Cash Reserves Shrink

Hesai Group’s Milestone Profit Tempered by Cautious Guidance

PagerDuty Charts a New Course with Autonomous AI Systems

Lexaria Bioscience Targets Multi-Billion Dollar Market with Side-Effect Solution

Watsco’s Dividend Hike Contrasts with Operational Headwinds

Trending

Talphera Stock
Analysis

Talphera Shares Slide as Funding Concerns Overshadow Clinical Progress

by Jackson Burston
March 25, 2026
0

Despite reporting operational headway and a narrower-than-expected quarterly loss, Talphera's stock experienced significant selling pressure. The market's...

Hain Celestial Stock

Hain Celestial Sheds Snack Division in Strategic Overhaul

March 25, 2026
Technology Select Sector SPDR® Fund Stock

Technology Sector Faces Mounting Headwinds as AI Hype Meets Macroeconomic Reality

March 25, 2026
Lumen Stock

Lumen’s AI Infrastructure Push Gains Recognition Amid Strategic Overhaul

March 25, 2026
Microsoft Stock

Microsoft’s AI Ambitions Strain Finances as Cash Reserves Shrink

March 25, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Talphera Shares Slide as Funding Concerns Overshadow Clinical Progress
  • Hain Celestial Sheds Snack Division in Strategic Overhaul
  • Technology Sector Faces Mounting Headwinds as AI Hype Meets Macroeconomic Reality

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com